These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9237800)

  • 1. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE
    J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
    Hamilton JA; Chan J; Byrne RJ; Bischof RJ; Jaworowski A; Kanagasundaram V
    J Immunol; 1998 Dec; 161(12):6802-11. PubMed ID: 9862711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice.
    Schaefer CJ; Wooley PH
    J Rheumatol; 1999 Oct; 26(10):2215-21. PubMed ID: 10529143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P
    Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
    Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice].
    Zhai ZF; Zhou CL; Zhong BY; Ao JH; Hao F
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):406-10. PubMed ID: 18581896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R; van Bruggen MC; Oppers-Walgreen B; Rijke TP; Berden JH
    Arthritis Rheum; 2001 Jun; 44(6):1320-30. PubMed ID: 11407691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice.
    Hong YH; Huang CJ; Wang SC; Lin BF
    Lupus; 2009 Mar; 18(3):206-15. PubMed ID: 19213858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice.
    Hong Y; Wang T; Huang C; Cheng W; Lin B
    Lupus; 2008 Sep; 17(9):814-21. PubMed ID: 18755863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
    Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K; Hamano T; Kakishita E
    Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice.
    Zhao JH; Sun SJ; Horiguchi H; Arao Y; Kanamori N; Kikuchi A; Oguma E; Kayama F
    Int Immunopharmacol; 2005 Oct; 5(11):1601-10. PubMed ID: 16039550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.